Heart failure is a leading cause of mortality and morbidity in the developed world, partly because mammals lack the ability to regenerate heart tissue. Whether this is due to evolutionary loss of regenerative mechanisms present in other organisms or to an inability to activate such mechanisms is currently unclear. Here we decipher mechanisms underlying heart regeneration in adult zebrafish and show that the molecular regulators of this response are conserved in mammals. We identified miR-99/100 and Let-7a/c and their protein targets smarca5 and fntb as critical regulators of cardiomyocyte dedifferentiation and heart regeneration in zebrafish. Although human and murine adult cardiomyocytes fail to elicit an endogenous regenerative response after myocardial infarction, we show that in vivo manipulation of this molecular machinery in mice results in cardiomyocyte dedifferentiation and improved heart functionality after injury. These data provide a proof of concept for identifying and activating conserved molecular programs to regenerate the damaged heart.
In Brief
Zebrafish have an inherent capacity to regenerate injured hearts, whereas adult mammals have lost this capacity. Izpisua Belmonte and colleagues now identify mechanisms underlying cardiac regeneration in zebrafish that are conserved yet inactive in mammals, and experimental reactivation of these effectors is sufficient to regenerate infarcted myocardium in mammals.
INTRODUCTION
Cardiovascular diseases remain the major contributors to the high mortality and morbidity rates in developed countries. Heart failure due to poor ventricle myocardial contractile performance has become a worldwide public health problem. Noticeably, adult mammalian hearts have been shown to elicit a primitive regenerative response upon injury (Addis and Epstein, 2013; Aguirre et al., 2013; Laflamme and Murry, 2011) . Supporting this notion, mature differentiated mammalian cardiomyocytes have been shown to re-enter the cell cycle upon application of chemical compounds targeting specific signaling pathways (Bersell et al., 2009) . However, in all cases, the regenerative response is insufficient for the healing and complete recovery of myocardial function. Interestingly, lower vertebrates such as the zebrafish are able to naturally activate endogenous regenerative responses that lead to complete heart regeneration throughout their entire lifetime by a process of cardiomyocyte dedifferentiation (Jopling et al., 2010; Kikuchi et al., 2010; Poss et al., 2002; Raya et al., 2003) . Dedifferentiated cardiomyocytes were shown to re-enter the cell cycle and accounted for all newly formed cells repairing the heart (Jopling et al., 2010; Kikuchi et al., 2010) . Different hypotheses have been considered to explain these different responses across species (Brockes and Kumar, 2008; Poss, 2010) . One possibility is that regenerative mechanisms have been positively or negatively selected during evolution and are therefore absent in the mammalian genome. Alternatively, regenerative mechanisms, following injury, even though present, might remain silenced due to differences in epigenetic regulatory mechanisms when compared with species able to regenerate (Brockes and Kumar, 2008; Kragl et al., 2009; Lehoczky et al., 2011; Seifert et al., 2012; Stewart et al., 2009) . Certain regenerative processes present in neonate mammals and redolent of development have been described (Porrello et al., 2011; Xin et al., 2013a) . Moreover, a recent finding has reported regeneration in several tissues upon metabolic reprogramming and manipulation of Lin28. However, despite successful in several tissues, adult murine heart regeneration could not be accomplished by this approach (Shyh-Chang et al., 2013a) . Therefore, the mechanisms underlying heart regeneration and whether they can be activated in adult individuals remain obscure (Aguirre et al., 2013; Xin et al., 2013b) .
Here we investigate the regenerative mechanisms controlling adult zebrafish heart regeneration and cardiomyocyte dedifferentiation and demonstrate that similar mechanisms are indeed present, yet dormant, in adult mammals. As a response to injury, we identify miR-99/100 and Let-7a/c downregulation and the subsequent upregulation of two of their target genes, fntb and smarca5 as critical steps required for heart regeneration in the adult zebrafish. This process fails to be activated in adult mammals upon injury. Experimental modulation in mice of any of the identified molecules in zebrafish, whether by anti-miR delivery or overexpression of their downstream targets FNTb and SMARCA5, results in adult cardiomyocyte dedifferentiation, the activation of a proliferative response, and ultimately, facilitates mammalian heart regeneration in vivo.
RESULTS
Mechanisms Controlling Zebrafish Heart Regeneration Are Conserved in the Mammalian Genome We and others have previously described that adult zebrafish heart regeneration occurs at the cellular level by dedifferentiation of mature cardiomyocytes followed by proliferation and further redifferentiation (Jopling et al., 2010; Kikuchi et al., 2010) . More recently, it has been shown that epigenetic remodeling is a key step controlling regenerative processes (Kragl et al., 2009; Zhang et al., 2013) . To further investigate the pathways underlying heart regeneration, we decided to focus on microRNAs (given their wide potential to regulate gene expression changes) differentially regulated during zebrafish heart regeneration (Eulalio et al., 2012; Ivey and Srivastava, 2010) . Three days postamputation (dpa) of the ventricular apex, we observed significant changes in the expression of 60 microRNAs ( Figure S1A available online). We focused our attention on those microRNAs presenting significant expression changes that were additionally conserved to a high degree across vertebrates, both in micro-RNA sequence and 3 0 UTR binding sites. This approach identified two microRNA families (miR-99/100, let-7a/c), which were clustered in two well-defined genomic locations (miR-99/Let7c and miR-100/Let-7a; Figure S1B ) and strongly downregulated during regeneration (Figures 1A and S1A) . Bioinformatic analysis for gene ontology (GO) processes controlled by these two micro-RNA clusters indicated significant enrichment in proliferation pathways, as well as processes related to chromatin remodeling and morphogenesis (Han et al., 2011; Paige et al., 2012) (Figure S1C and Table S1 ). Interestingly, Let-7a/c upregulation has been previously reported as an important regulator of stem cell differentiation, and Lin28-mediated Let-7a/c downregulation has been linked to regenerative processes (Shyh-Chang et al., 2013a . A recent report also indicates a common role for the miR-99a/let-7c cluster in regulating cardiomyogenesis (Coppola et al., 2014) . Together, Let-7a/c represents an interesting candidate for controlling heart regeneration in combination with miR-99/100. Next, we sought to identify downstream targets for miR-99/100. MIRANDA-based microRNA-UTR binding predictions suggested downstream targets, and a strong interaction was found for microRNA-99/100 with zebrafish fntb (beta subunit of farnesyl-transferase) and smarca5 (SWI/SNF-related matrix associated actin-dependent regulator of chromatin subfamily a, member 5) ( Figure S1D ). Confirming our predictions, gene expression analysis of fntb and smarca5 highlighted a significant upregulation of both genes, paralleling the downregulation of miR-99/100 and Let-7a/c during zebrafish heart regeneration ( Figures 1A and 1B) . ClustalX alignment of the 3 0 UTRs on the three species showed that the interactions sites were highly evolutionarily conserved in all of them (data not shown). Bioinformatic predictions allow for the prescreening of potential miRNA target sequences; however, they do not unequivocally identify target genes, and potential targets need to be validated by further biochemical approaches. As reported in other species, luciferase reporter assays confirmed microRNA binding predictions to both the human and zebrafish fntb and smarca5 3 0 UTRs (Mueller et al., 2012; Brenner et al., 2012; Chen et al., 2013; Liang et al., 2014; Sun et al., 2011) (Figure S1E ). Together, these results demonstrate that both fntb and smarca5 mRNAs are direct targets of miR-99/100.
Regenerative Pathways Are Involved in Zebrafish and Mammalian Heart Development but Fail to be Activated in the Injured Mammalian Heart To shed new light onto the biological role of miR-99/100, we investigated their potential functional implication in heart development as well as during heart regeneration. Because of its involvement in controlling stem cell differentiation and regeneration as well as its connections to miR-99/100 (Shyh-Chang et al., 2013a; Coppola et al., 2014) , we also studied the role of Let-7a/c. Quantitative RT-PCR (qRT-PCR) and immunofluorescence analyses demonstrated low levels of miR-99/100 expression during early zebrafish heart development concomitantly with high levels of Smarca5 and Fntb ( Figures 1C-1F ). Next, we sought to establish a mechanistic link between the identified microRNAs and the predicted target proteins, Fntb and Smarca5. To do this, we performed injection of antago-miRs blocking miR-99/100 and Let-7 in adult uninjured zebrafish. As shown in Figure S1F , injection of (C) Real-time RT-PCR revealed that expression of miR-99/100 is very low during the first stages of development and dramatically increased at 3 dpf in zebrafish (n = 10). (D) fntb and smarca5 expression inversely correlates with miR-99/100 in developing embryos (n = 10). Note that in (C) and (D) analyses were done in whole embryos at 1, 3, and 5 dpf, and whole heart at the adult stage. (E and F) Representative pictures demonstrating that both Fntb and Smarca5 are present at high levels in the ventricles of developing hearts at 2 and 5 dpf (n = 10). V, ventricle; A, atrium; Eb, erythroblasts. (G-I) Knockdown of fntb and/or smarca5 in zebrafish embryos resulted in abnormally small animals (G) and reduced ventricle size in cmlc2:GFP animals (H and I). The same phenotypes were observed upon injection of miR-99/100 mimics (G-I) (n > 50). (J) Rescue experiments for the conditions tested in (G) were performed by c-injecting in vitro transcribed mRNAs with modified 5 0 UTRs with corresponding MOs to determine the specificity of the observed phenotypes (n = 30).
(K) Quantification of the ventricle size for the rescue experiments. Data are represented as mean ± SEM. *p < 0.05. See also Figure S1 and Table S1 . (Figures 1J and 1K) . Together, these results confirmed the specificity of the MOs used in these studies as well as demonstrate a causal link in controlling SMARCA5 and FNTb expression either by stabilizing their respective mRNAs or upon modulation of other factors controlling their transcription. Next, we monitored miR-99/ 100 as well as Fntb and Smarca5 expression in the regenerating zebrafish heart. Confirming our initial observations, miR-99/100 expression was high and confined to cardiomyocytes in uninjured hearts and became almost undetectable upon injury (Figures 2A, 2B , S2A, and S2B). As expected, miR-99/100 downregulation was paralleled by upregulation of their protein targets Fntb and Smarca5 (Figures 2A, 2B , S2A, and S2B). Immunofluorescence analyses further correlated Fntb and Smarca5 expression with increased histone 3 phosphorylation (H3P) and proliferating cell nuclear antigen (PCNA) re-expression, both indicative of cellular proliferation and cardiomyocyte dedifferentiation (Jopling et al., 2010; Kikuchi et al., 2010) (Figures 2C-2F ). Let-7a/c expression was also maximal in adult uninjured zebrafish hearts ( Figure S2C ). Following amputation, we observed Let7a/c downregulation ( Figures 1A and S2C ) accompanied by the upregulation of its previously described target genes, ras and c-myc ( Figures S2D-S2G ). miR-99/100 and Let-7a/c expression, as well as that of their respective protein targets, returned to basal levels 30 dpa once regeneration of the ventricle was nearly completed (Figures S3A and S3B) . Next, we designed a series of in vivo experiments to functionally dissect the role of miR-99/100 in the adult regenerating zebrafish heart. Notably, we first injected miR-99/100 mimics and evaluated fntb and smarca5 expression during regeneration. As expected, avoiding downregulation of miR99-100 during regeneration significantly impaired fntb and smarca5 expression ( Figure S3C ), confirming further that the miR-99/100 cluster does influence the activity of its targets in vivo. Intracardiac injection of miR-99/100 mimics efficiently blocked the regenerative response in all amputated animals ( Figures 3A and 3B ). Reduced bromodeoxyuridine (BrdU) incorporation indicated that cardiomyocyte proliferation was significantly disrupted in mimic-treated animals (Figures 3A and 3C) . Inversely, microRNA inhibition in uninjured adult animals led to significantly enlarged zebrafish hearts, suggesting a regenerative proliferative response even in the absence of injury and therefore a direct role for miR-99/100 in controlling heart mass ( Figures 3D-3F ). Most interestingly, chemical inhibition of Fnt with the specific antagonist tipifarnib significantly impaired heart regeneration by decreasing the number of proliferating cardiomyocytes, further suggesting an active role for miR-99/100 targets during regeneration ( Figures 3G-3I ). Taken together, these results demonstrate a functional role for miR-99/100, Fntb, and Smarca5 in zebrafish heart development and adult heart regeneration.
We next sought to investigate whether mammals presented similarities with the adult zebrafish in terms of miR-99/100 and/ or Let-7a/c expression and functionality. Therefore, we first evaluated miR-99/100, Let-7a/c, and FNTb/SMARCA5 expression at different stages during murine and human cardiomyocyte differentiation and heart development. qRT-PCR and immunofluorescence analyses demonstrated the progressive upregulation of miR-99/100 and Let-7a/c as heart development and maturation proceeds (Figures 4A-4G and S4A-S4C). Interestingly, neonatal murine cardiomyocytes, which although still proliferative quickly lose those capabilities after birth, presented significantly higher levels of miR expression than embryonic cardiomyocytes, and no Fntb neither Smarca5 mRNAs could be detected ( Figures  4C and 4D ). Thus, suggesting that higher levels of miR-99/100 and Let-7a/c are required for cardiomyocyte maturation in line with a recent report by Coppola et al. (2014) or, alternatively, that distinct mechanisms control neonatal and adult cardiomyocyte proliferation. By employing human embryonic stem cellderived cardiomyocytes, we were able to partially recapitulate human cardiomyocyte development in a dish, revealing that low levels of miR-99/100 and high levels of FNTb/SMARCA5 are necessary at early stages for cardiac specification and are lost when cardiomyocytes mature (data not shown). Adult murine and human heart tissue demonstrated extremely high levels of miR-99/100, a point at which FNTb/SMARCA5 expression was undetectable ( Figures 4A-4G ). Interestingly, analyses of postmortem injured human heart tissue suggested a failure to upregulate FNTb/SMARCA5 expression, while both proteins were expressed in the developing embryonic human heart but absent in the adult ( Figure S4D ). To further demonstrate that this was not due to the temporal window analyzed, as adult human hearts can rarely be obtained from an individual right after an infarction has occurred, we additionally performed myocardial infarction experiments in adult mice. Our results indicated that murine hearts are unable to elicit a natural downregulation of miR-99/100 and Let-7a/c and presented levels comparable to those observed on sham-operated animals ( Figures 4H,  S4E , and S4F). Collectively, these results suggested that adult (A-C) Following adult zebrafish heart amputation, exogenous intracardiac administration of 0.2 mg miR-99/100 mimics every second day for a total of 14 days led to defective cardiac regeneration in amputated zebrafish (A, upper row), as determined by reduced BrdU incorporation (A, lower row and C). (D-F) miR-99/100 antagomiRs exerted the opposite effect in uninjured adult animals, inducing a significant increase in ventricle size (D, upper panels, and E) and increasing cardiomyocyte proliferation in the absence of heart damage (D, lower panels, and F). (G-I) Chemical inhibition of fnt activity with tipifarnib upon intraperitoneal injection (final concentration 0.02 mg per animal) every 2 days for 14 days dramatically reduced heart regeneration in amputated zebrafish as compared with control animals administered with the solvent DMSO control (G and H) and reducing cardiomyocyte proliferation as assessed by BrdU incorporation (G, lower panels, and I) . Dashed line, amputation plane; boxed area, magnified detail. Data are represented as mean ± SEM. *p < 0.05; n = 6 animals. Three different sections per animal were used for quantitative analyses. mammals, in contrast to zebrafish, might fail to regenerate their heart due to a failure in downregulating miR-99/100 and Let-7a/c and, inversely, upregulate the miR-99/100 targets, FNTb/ SMARCA5, after injury.
Experimental Manipulation of Conserved Regenerative Pathways Allows Mammalian Cardiomyocyte Proliferation by Cell Dedifferentiation
Adult zebrafish heart regeneration occurs by the spontaneous dedifferentiation of resident cardiomyocytes as a response to injury. Recently, dedifferentiation of somatic cells to a progenitor-like state with proliferative and redifferentiation potential has been described to occur as a consequence to injury in a number of different mammalian organs, including the gut and pancreas (Schwitalla et al., 2013; Zaret, 2008; Ziv et al., 2013) , as an attempt to maintain tissue homeostasis. Neonatal murine heart regeneration by enhanced cardiomyocyte proliferation has been reported (Porrello et al., 2011 ), yet whether de novo proliferative cardiomyocytes were generated by dedifferentiation as opposed to boosting the inherent proliferative capacity of neonatal murine cardiomyocytes remains unknown. More interestingly, recent reports indicate that neonatal heart regeneration is accomplished by neovascularization and not necessarily cardiomyocyte dedifferentiation (Andersen et al., 2014) . Regardless the case, cell dedifferentiation and repair do not naturally occur in the adult mammalian heart upon injury to any significant extent (Senyo et al., 2012) . Therefore, we next wondered whether experimental downregulation of miR-99/100 and/or let-7a/c in vitro and ex vivo or, inversely, experimental upregulation of SMARCA5 and FNTb, in mammalian cardiomyocytes, could lead to dedifferentiation in an analogous manner to that observed during zebrafish heart regeneration. Seven days after miR-99/100 and/or let-7a/c silencing by anti-miR delivery (Figures S5A and S5B) , significant upregulation of SMARCA5 and FNTb was observed in cultured adult primary murine cardiomyocytes compared with the respective scrambled and mock vector controls ( Figures 5A-5C ). Importantly, an increased amount of GATA4, a marker associated with dedifferentiated cardiomyocytes (Kikuchi et al., 2010) , was also observed ( Figures 5A, 5B , and 5D). Accompanying dedifferentiation we observed PCNA re-expression ( Figures 5A, 5B , and 5D) and increased formation of human cardiomyocyte beating colonies (Movies S1, S2, and S3), suggesting the acquisition of a proliferative phenotype similar to that observed during zebrafish regeneration (Jopling et al., 2010; Kikuchi et al., 2010) . In support of cardiomyocyte specificity, microRNA downregulation did not affect proliferation nor FNTb/SMARCA5 expression in human fibroblasts or vascular cells (Figures S5C and S5D ). To provide further insights into the gene expression changes occurring during mammalian cardiomyocyte dedifferentiation, neonatal cardiomyocytes were transduced with the different anti-miRs and their respective negative control. Seven days after infection, GFP + cells were sorted out and analyzed by RNA-seq (Figures S5E  and S5F and Table S2 ). Transcriptomic analysis revealed differences in genes involved in epigenetic remodeling and demethylation, cardiac development, proliferation, and unexpectedly, metabolic pathways ( Figures 5E-5H and S5G) . Furthermore, and in an effort to offer a more comprehensive view of transcriptomic changes, we performed semiquantitative mass spectrometry on regenerating zebrafish hearts, neonatal mouse hearts, and ex vivo adult myocardial mouse tissue treated with the anti-miRs to find out changes at the translational level ( Figure 5I and Table S3) . A cross-species comparison of the differentially regulated proteins confirmed the transcriptomic findings and identified dozens of metabolic and mitochondrial processes as key actors, while also highlighting changes in the cytoskeleton and chromatin state in the regeneration-permissive state (Figure S5H and Table S3 ). Given the newfound importance of metabolic processes and considering that changes in metabolism have been ascribed to the dedifferentiation of somatic cells to induced pluripotent stem cells (iPSCs) (Panopoulos et al., 2012; Shyh-Chang et al., 2013b) and regeneration (Shyh-Chang et al., 2013a), we decided to investigate whether similar processes underlined anti-miR-elicited cardiomyocyte dedifferentiation. First, since Lin28 expression has been linked to an increase in oxidative phosphorylation, regeneration, and Let7a/c biogenesis, we evaluated Lin28 expression in primary adult murine cardiomyocytes subjected to anti-miR treatments. qPCR analyses demonstrated lack of Lin28 mRNA in any of the analyzed conditions (data not shown), in line with previous reports demonstrating that Lin28-mediated responses were context specific and did not result in heart regeneration (ShyhChang et al., 2013a) . Along the same line, seahorse analysis indicated an increase in the ratio between glycolysis and oxidative phosphorylation in line with the metabolic changes observed during dedifferentiation to iPSCs ( Figure S6A ). Interestingly, mitochondrial fusion has been recently described to accompany cardiomyocyte differentiation (Kasahara et al., 2013) . In line with these observations, we observed a highly fused and organized mitochondrial network in differentiated primary cardiomyocytes, whereas anti-miR delivery resulted in mitochondrial network fragmentation indicating cardiomyocyte dedifferentiation (Figure S6B) . We then decided to employ a different experimental setting closer to in vivo conditions-i.e., ex vivo myocardial tissue cultures of adult murine hearts-to further understand the whole extend of the dedifferentiation process. Ex vivo tissue has the advantage of providing a microenvironment more closely resembling that present in the heart. Lentiviral-mediated silencing of miR-99/100 and/or miR-Let-7a/c to hypoxic and nonhypoxic murine heart organotypic slices (Brandenburger et al., 2012) (Figure 6A ) resulted in sarcomeric disassembly (Figure 6B ) and the downregulation of Connexin 43 (Cx43) and MyHC ( Figures 6C, 6D , and S6C). Accompanying cardiomyocyte dedifferentiation, H3 phosphorylation, and re-expression of GATA4 were also observed ( Figures 6C, 6D , and S6C). Moreover, necrosis, which is readily observed in control organotypic slices subjected to hypoxia, was reduced after anti-miR delivery ( Figure 6E ). Taken together, our results demonstrate that experimental downregulation of miR-99/100 and Let-7a/c triggers the dedifferentiation of mammalian cardiomyocytes to a proliferative state able to reduce necrosis ex vivo.
Considering that microRNAs are pleiotropic molecules controlling expression of multiple downstream target genes, we next sought to investigate whether FNTb/SMARCA5 upregulation alone could suffice for the induction of cardiomyocyte dedifferentiation and proliferation in mammalian cardiomyocytes. We speculated that if the main role of miR-99/100 during heart regeneration was to upregulate endogenous 
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Induction of Mammalian Heart Regeneration FNTb/SMARCA5 expression, overexpression of these proteins might allow bypassing the requirement for microRNA downregulation altogether. Indeed, overexpression of either protein in primary murine cardiomyocytes cultured in vitro resulted in the appearance of dedifferentiated phenotypes, including GATA4 expression and ultimately, cell proliferation ( Figure 6F ). To further demonstrate specificity, we devised an experimental design conceptually similar to traditional rescue experiments. In contrast to our overexpression experiments, should FNTb and SMARCA5 be the major players controlling mammalian cardiomyocyte dedifferentiation and heart regeneration downstream of miR-99/100, concomitant siRNA-mediated knockdown of Fntb and Smarca5 alongside delivery of anti-miR-99/100 should result in impaired cardiomyocyte dedifferentiation and proliferative potential. As expected, downregulation of the downstream effectors Fntb and Smarca5 in anti-miR-99/100-treated cells significantly abrogated mammalian cardiomyocyte dedifferentiation and proliferation ( Figure 6G ). Finally, we wondered whether miR-99/100 and let-7 levels, and inversely FNTb and SMARCA5 levels, correlated not only with cardiomyocyte dedifferentiation but also reciprocally with cardiomyocyte specification. In line with recent findings (Coppola et al., 2014) reporting a positive effect of the miR-99/let-7 cluster during embryonic stem cellcardiomyocyte differentiation by enhancing mesoderm specification, our results further demonstrated that expression of miR-99/100 and let-7 mimics, or inversely knockdown of FNTb and SMARCA5, resulted in the maturation of embryonic stem cell-derived human cardiomyocytes, Interestingly, we observed a significant upregulation of genes typically associated to adult mature cardiomyocytes including CX43 and MYL7 ( Figure S6D ). Together, these results highlight FNTb and SMARCA5 as critical targets downstream of miR-99/100 for controlling mammalian cardiomyocyte dedifferentiation and inversely maturation.
Induction of Cardiomyocyte Dedifferentiation Facilitates Mammalian Heart Regeneration In Vivo
Finally, we decided to test the in vivo regenerative potential of anti-miRs delivery in a murine model of MI. Following left anterior descending (LAD) artery ligation, we first focused on the use of lentiviral vectors encoding anti-miR-99/100 and anti-Let-7a/c and the respective mock controls. Intracardial delivery of lentiviruses resulted in significantly improved functional parameters, including ejection fraction (EF) and fraction shortening (FS) as compared with nontreated animals ( Figure S7A ). Indeed, the values achieved 15 days after treatment did not significantly differ from those obtained in sham-operated animals. To evaluate the potential therapeutic use of anti-miR-99/100 and antiLet-7a/c, we next decided to use adeno-associated viruses serotype 2/9 (AAV2/9) presenting cardiac tropism. AAVs encoding for anti-miR-99/100 and anti-Let-7a/c, or the respective scrambled controls, were administered by intracardiac injection in the periphery of the infarcted area. Importantly, functional heart parameters, as determined by echocardiography, including FS, EF, and ventricular wall thickness, significantly improved in the treated group after 14 and 90 days, as compared with scrambled controls, to levels closer to those observed in sham-operated animals but significantly different ( Figures 7A  and S7B-S7D) . In addition, a significant reduction in fibrotic scarring as well as in infarct size was observed when treated injured animals were compared with scrambled MI controls (Figures 7B, 7C, S7E , and S7F). To determine whether cardiomyocyte dedifferentation and proliferation were taking place, we performed histological analyses. Our results revealed increased numbers of cardiomyocytes positive for the miR-99/100 target genes FNTb and SMARCA5 18 days after injury in anti-miRstreated animals ( Figures 7D and 7E) . Additionally, since knockdown of FNTb and SMARCA5 facilitated cardiomyocyte maturation, we wondered whether functional improvement could be due to the specification of resident cardiac precursors. Interestingly, re-expression of GATA4 and PCNA ( Figures 7F, 7G , S7G, and S7H) alongside increased H3 phosphorylation and BrdU incorporation ( Figures 7H, 7I, S7I , and S7J) demonstrated increased DNA synthesis, suggesting a process of cardiomyocyte dedifferentiation. However, whereas we fail to observe a substantial population of GATA4 + or PCNA + cells in scrambled-treated or in sham-operated animals, we cannot totally rule out a contribution from cardiac precursors in this system. To rule out the possibility that DNA synthesis was occurring independently of cell division, we next investigated the expression of aurora B kinase (ARK-2) and anillin, both indicative of cytokinesis. ARK-2 and anillin expression were readily observed in regenerating murine hearts ( Figures 7J and S7K ). In conclusion, our data demonstrate that failure to naturally downregulate miR-99/100 and Let-7a/c and subsequent upregulation of their target genes FNTb and SMARCA5 as a response to heart injury acts as a major roadblock preventing adult mammalian heart regeneration. More interestingly, barriers to mammalian heart regeneration could be experimentally overcome by anti-miR administration.
DISCUSSION
Despite the fact that yet unknown mechanisms prevent adult mammals to naturally mount a robust and efficient regenerative response upon injury (Senyo et al., 2012) , our results and those from others indicate that heart regeneration can be activated in mammals under certain circumstances (Porrello et al., 2011 (Porrello et al., , 2013 Senyo et al., 2012) . Porrello et al. first demonstrated that an efficient regenerative response occurs in the neonatal murine heart during the days immediately after birth. This regenerative (C and D) qRT-PCR analysis showing the expression of miR-99/100 and Let-7a/c (C), their protein targets and key cardiac transcription factors (D) during mouse development and adult stages (n = 5). mESCs, mouse embryonic stem cells.
(E-G) FISH/immunofluorescence (E and F) and quantitative analysis (G) demonstrating low levels of miR-99/100 and high levels of FNTb and SMARCA5 in E11 murine embryonic hearts as opposed to adult hearts, which showed high levels of miR-99/100 and almost undetectable expression of FNTb and SMARCA5. (H) FISH/immunofluorescence in adult mouse heart before (upper panels) and after MI (lower panels) highlighted a failure to downregulate miR-99/100 upon injury in the murine heart. Data are represented as mean ± SEM. *p < 0.05. (E and F) n = 6 animals; (H) n = 5 animals. In all cases, three different sections per animal were used for quantitative analyses (G) . See also Figure S4 . 
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Induction of Mammalian Heart Regeneration response is completely absent from day 8 onward and in adult animals. Interestingly, neonatal murine cardiomyocytes differ from adult cardiomyocytes in that they are able to naturally proliferate. Therefore, it remains unclear whether neonatal murine heart regeneration is due to enhanced cardiomyocyte proliferation or to a regenerative response mounted de novo. Most strikingly, neonatal murine heart regeneration has been recently ascribed to neoangiogenesis as opposed to a major contribution due to newly generated myocardial mass (Andersen et al., 2014) .
Regardless of the precise mechanisms, these observations collectively suggest that developmental mechanisms are still present in the neonatal murine heart and that they might contribute to tissue repair by promoting cardiomyocyte proliferation. Indeed, our previous work identified microRNAs boosting cardiomyocyte proliferation in neonatal murine cardiomyocytes that sufficed for the partial healing of the mammalian heart (Eulalio et al., 2012), albeit the mechanisms at work remain obscure. In contrast to neonate murine models, the adult heart is largely comprised of postmitotic cardiomyocytes. Indeed, natural regeneration is preceded by cardiomyocyte dedifferentiation and proliferation in organisms able to regenerate their adult heart (Jopling et al., 2010; Kikuchi et al., 2010; Witman et al., 2011) . These dedifferentiated cardiomyocytes are able to re-enter the cell cycle and fully repair the injured adult heart as a response to injury (Jopling et al., 2010; Raya et al., 2003; Wang et al., 2011) . Interestingly, similar proregenerative phenomena, based on cell dedifferentiation, have been recently described to underlie mammalian tissue repair and homeostasis as a response to injury in the pancreas and intestine (Schwitalla et al., 2013; Zaret, 2008) . However, mammalian hearts do not regenerate, nor do adult mammalian cardiomyocytes naturally dedifferentiate to a proliferative state upon injury (Jopling et al., 2011) . Here we sought to identify the molecular mechanisms regulating cardiomyocyte dedifferentiation in the zebrafish heart and speculated that, if conserved, they might provide a platform for the development of in vivo regenerative strategies for the healing of the mammalian heart. By systematic screening of molecules differentially regulated during zebrafish heart regeneration, we report on the identification of the molecular effectors controlling zebrafish heart regeneration and their application for the induction of regeneration in the injured adult mammalian heart. miR-99/100 expression was high in the uninjured zebrafish heart and underwent rapid downregulation upon injury. Concomitant to miR-99/100 downregulation, expression of multiple downstream target genes was observed. Among all different target genes, we identified fntb and smarca5 as critical regulators of zebrafish heart development and regeneration. Interestingly, similar patterns of expression were observed during mammalian heart development. Mature nonproliferative cardiomyocytes in the zebrafish, human, and mouse demonstrated maximal levels of microRNA expression accompanied by absent GATA4, FNTb, and SMARCA5 expression. Noticeably, whereas the adult zebrafish efficiently downregulated miR-99/100 expression to undergo regeneration as a response to injury, mammals seemingly failed to endogenously activate such mechanisms in spite of being present and playing the exact same role. Experimental downregulation of miR99-100 in human, neonatal, and adult murine cardiomyocytes resulted in the acquisition of a dedifferentiated phenotype, as best exemplified by GATA4 re-expression, expression of proliferative markers, and sarcomeric disassembly. Noticeably, dedifferentiation seemed limited to mononucleated cardiomyocyte populations, raising the interesting question of whether mononucleated cardiomyocytes are more responsive to the activation of this signaling pathway or alternatively that polynucleated/polyploidy cardiomyocytes can somehow revert to a mononucleated state. Genetic lineage tracing approaches might be able shed some light on this issue in the future.
Among all different target genes regulated by miR-99/100, we unveiled two major proteins, FNTb and SMARCA5, as critical regulators of mammalian cardiomyocyte dedifferentiation and regeneration. Overexpression of either protein resulted in mammalian cardiomyocyte dedifferentiation and induction of proliferation even when miR-99/100 expression was not experimentally downregulated, a phenomenon enhanced when both proteins were simultaneously overexpressed. Conversely, downregulation of miR-99/100 by anti-miR delivery in the presence of siRNAs targeting Fntb and Smarca5 abrogated mammalian cardiomyocyte dedifferentiation and proliferation. Instead, miR-99/ 100 and let7 overexpression, or inversely Fntb and Smarca5 knockdown, facilitated cardiomyocyte maturation.
Interestingly, metabolic reprogramming as a response to Lin28 upregulation, a regulator of let-7 biogenesis, has been shown to elicit a regenerative response in mammalian organs other than the heart (Shyh-Chang et al., 2013a) . Thus, adult mammalian heart regeneration might be subjected to different mechanisms in a context-dependent manner. Indeed, our results indicate that treatment with Let-7a/c alone did not suffice for mounting an efficient regenerative response, as observed by incomplete sarcomeric disassembly, whereas blocking miR-99/100 efficiently led to sarcomeric disassembly and GATA4 expression, indicating cell dedifferentiation. More robust results in inducing cardiomyocyte dedifferentiation and adult heart regeneration were obtained when both miR99-100 and Let7c (G) and downregulated (H) groups involved in cardiomyocyte dedifferentiation. As expected, epigenetic remodeling and developmental processes appeared as highly represented. (I) Comparative proteomic analysis of the heart during regenerative stages. Adult regenerating zebrafish hearts (uninjured, 3 dpa, 7 dpa), neonatal regenerationpermissive mouse hearts (P0, P7, adult), and anti-miR treated adult myocardial mouse tissue (control, anti-miR-99/100, anti-Let-7a/c, anti-miR-99/100+anti-Let7a/c) were collected and processed for semiquantitative mass spectrometry to determine their translational profiles. The Venn diagram depicts differentially regulated protein candidates for each stage and species after a cross-comparison to find common protein effectors involved in the maintenance or transition to a regeneration-permissive state. Data are represented as mean ± SEM. *p < 0.05; n = 3 independent experiments. See also Figure S5 and Tables S2 and S3. 
Induction of Mammalian Heart Regeneration were inhibited by their respective anti-miRs, therefore suggesting that sarcomeric disassembly represents a barrier to the dedifferentiation effect of Let-7. Ultimately, modulation of the identified regenerative machinery in adult murine models of MI resulted in the significant improvement of heart functionality. Induced mammalian heart regeneration seems to be accomplished by a process of cardiomyocyte dedifferentiation resembling what naturally occurs in the zebrafish as a response to injury (Jopling et al., 2011; Laflamme and Murry, 2011) .
Our results represent a proof of concept on how the identification of conserved regenerative effectors in animal models naturally able regenerate their tissues may serve for the development of strategies toward inducing in vivo reprogramming to a dedifferentiated state in mammals. Altogether, in vivo activation of conserved cardiac regenerative mechanisms may help to circumvent concerns associated with heart cell transplantation as well as those associated with other reprogramming technologies (Abad et al., 2013; Aguirre et al., 2013; Qian et al., 2012; Song et al., 2012; Vierbuchen and Wernig, 2011) , adding an additional tool to the clinical armamentarium of regenerative medicine toward the treatment of human heart disease.
EXPERIMENTAL PROCEDURES Animals
All protocols were previously approved and performed under institutional guidelines. WT (AB) and cmlc2:GFP zebrafish were maintained at 28.5 C following standard methods. CD1 and C57BL mice were housed and maintained at the Salk Institute and ICGEB animal facilities. Mouse care and treatments were conducted in conformity with institutional guidelines in compliance with national and international laws and policies (EEC Council Directive 86/609, OJL 358, 12 December, 1987) (ICGEB). Zebrafish work was conducted in conformity with Salk Institute IACUC and AAALAC guidelines.
Zebrafish Heart Amputation Adult fish were anaesthetized in 0.4% Tricaine and secured, ventral side uppermost, in a slotted sponge. Watchmaker forceps were used to remove the surface scales and penetrate the skin, muscle, and pericardial sac. Once exposed, the ventricle was gently pulled at the apex and cut with iridectomy scissors. After surgery, fish were immediately returned to system water.
Myocardial Infarction
Myocardial infarction was induced in CD1 mice (8-12 weeks old) by permanent LAD coronary artery ligation as described elsewhere (Eulalio et al., 2012) . Briefly, mice were anesthetized with an injection of ketamine and xylazine and were intubated and placed on a rodent ventilator. Body temperature was maintained at 37 C. After removing the pericardium, a descending branch of the LAD coronary artery was visualized with a stereomicroscope and occluded with a nylon suture. Ligation was confirmed by the whitening of a region of the left ventricle. Recombinant AAV vectors or lentiviruses, at a dose of 10 11 viral genome particles per animal, were injected immediately after LAD ligation into the myocardium bordering the infarct zone (single injection), using an insulin syringe with incorporated 30-gauge needle. Several groups of animals were studied: receiving control lentiviruses (coding for an empty vector) or anti-miRs-99/100 and Let-7a/c coding lentiviruses or AAV9 controls (empty vector and scrambled shRNA-Luc) or AAV9-anti-miR-99/100 + AAV9-anti-Let-7a/c. Sham-operated groups and noninfarcted but injected groups were additionally included as control groups for AAV and lentivirus injected groups, respectively. The chest was closed, and the animals moved to a prone position until the occurrence of spontaneous breathing. Echocardiography analysis was performed at day 15 (lentiviral injections) or at days 14 and 90 (AAV-injected animals) after surgery, and hearts were collected at 18 and 90 days after infarction. All groups were analyzed in a blinded and randomized manner by a minimum of two experimenters.
Lentiviral and AAV Constructs
Anti-miR constructs, miRZip-99/100 and miRZip-let7 (SBI), were used according to the manufacturer's instructions. As respective controls, the anti-miRs were removed from the parent vector by digesting with BamH1 and EcoR1 and were end filled and religated. Lentiviruses were packaged by transfecting in 293T cells followed by spinfection in the respective mouse or human ESderived cardiomyocytes. AAVs were generated as described before (Eulalio et al., 2012) . Briefly, the anti-miR constructs contained in the miRZip vectors were excised and ligated into pZacf-U6-luc-ZsGreen. Serotype 9 AAVs were packaged by transfection of 293T cells with the appropriate plasmids.
Organotypic Heart Slice Culture Mice ventricles (C57BL) were washed in cold Modified Tyrode's Solution, embedded in 4% low melting point agarose, and immediately cut into 300 mm slices using a vibratome (Leica). Heart slices were then maintained in complete Iscove's modified Dulbecco's medium 5%, 1% Pent/Strep in 12-well plates at the medium-air interface using 0.4 mm membrane transwells (Corning) at 37 C in a 5% CO 2 incubator. For experimental hypoxia-like conditions, slices were kept in a hypoxia chamber incubator for 4 hr at 37 C, 5% O 2 . Lentiviral transduction was performed by immersion of the slices in virus-containing medium for 24 hr.
Confocal Microscopy
Samples were imaged using a Zeiss L710 confocal microscope. For every sample, at least two different fields were examined at two different magnifications (using a 203 objective and a 633 oil-immersion objective). Z stacks were obtained for further analysis and 3D reconstruction. For intensity comparison purposes, images were taken under the exact same conditions (pinhole size, laser intensity, etc.). Automatic cell counting was performed with ImageJ and Metamorph software.
Statistical Analysis
Results are expressed as mean ± SEM. Results are representative of at least three independent experiments except when otherwise indicated. Statistical analysis was carried out using Prism Software (GraphPad). For statistical comparison of two groups, unpaired, two-tailed Student's t test was used; for the 
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Induction of Mammalian Heart Regeneration comparison of three or more groups, one-way ANOVA followed by Tukey's post hoc test was used. A value of p < 0.05 was considered significant.
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